Nursing News and Research

Latest Nursing News and Research

Elsevier to celebrate medical education innovation at 60th AMSA convention

Elsevier, the leading publisher of scientific, technical and medical information, today announced it is celebrating medical education innovation at the American Medical Student Association's 60th Annual Convention, March 11-14, 2010, at the Disneyland Hotel in Anaheim, California.

22 Feb 2010

NHI reports normalized FFO of $16.65M for fourth-quarter 2009

National Health Investors, Inc. announced today its normalized Funds From Operations and net income for the three months and year ended December 31, 2009.

22 Feb 2010

PharMEDium Services participates in APSF Summit held in Phoenix, AZ

PharMEDium Services, LLC, announced their participation in the Anesthesia Patient Safety Foundation (APSF) Summit held January 26th in Phoenix, AZ.

22 Feb 2010

HTA executes purchase and sale agreement to acquire five building medical office portfolio in Indiana

Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a five building medical office portfolio located in Evansville, Indiana. The closing of the acquisition is subject to the satisfaction of a number of conditions.

20 Feb 2010

WSNA holds informational picket to highlight issues critical to public health and safety

Washington State Nurses Association, representing more than 300 registered nurses at Public Health - Seattle & King County, is holding an informational picket today to highlight issues critical to public health and safety. During stalled contract negotiations, public health nurses are deeply concerned that the administration's new limitations on work schedules will reduce the ability to meet the needs of patients and clients.

20 Feb 2010

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.

20 Feb 2010

Recession swells Medicaid rolls, shrivels treasuries

Nearly every state is considering or already making cuts to its Medicaid program as the recession swells rolls for the state-run health insurance program for the poor, The New York Times reports. Because of requirements for getting stimulus money to support programs, the states are not allowed to curb enrollment, and are instead cutting optional benefits and reimbursement rates. Lower rates could drive more physicians and other providers away from the program, which already pays very low fees.

19 Feb 2010

Petzel takes oath to lead nation's largest integrated health care system

Dr. Robert A. Petzel has taken the oath of office as the Under Secretary for Health within the Department of Veterans Affairs (VA), stepping up to lead the nation's largest integrated health care system.

19 Feb 2010

Accessing out of hours care: Challenging for UK palliative care patients

Accessing out of hours care is still a challenge for UK palliative care patients, even several years after the introduction of phone help line services like NHS24 and NHS Direct. Scottish researchers have specific recommendations for a more detailed and regular communication strategy to improve patients' care, which are published by SAGE in the journal Palliative Medicine.

19 Feb 2010

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Eclipsys Corporation®, The Outcomes Company®, today announced that Sound Shore Health System (SSHS) will undergo an accelerated activation of Eclipsys’ Sunrise Enterprise™ integrated suite of solutions at both its Sound Shore Medical Center of Westchester (New Rochelle, NY) and Mount Vernon Hospital (Mount Vernon, NY) facilities.

19 Feb 2010

Sacred Heart Medical Center fined $8,000 for failing to adhere to state and national H1N1 influenza safety standards

On January 29, 2010, Sacred Heart Medical Center was cited and fined $8,000 for failing to adhere to state and national H1N1 influenza safety standards. The Department of Labor and Industries Division of Occupational Safety and Health issued the citation and fine for violation of Center for Disease Control and Occupational Safety and Health Administration guidelines on H1N1 and also for violation of the DOSH Directive on Enforcement Procedures for High or Very High Occupational Exposure Risk to the 2009 H1N1 Influenza.

19 Feb 2010

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

19 Feb 2010

University of Missouri to offer health literacy courses for health professionals

The cost of low health literacy - the difference between patients' abilities to understand health information and providers' abilities to effectively communicate complex medical information - is $106 billion to $238 billion annually, according to Pfizer, a leading biopharmaceutical company. To improve the health literacy of professionals and patients, the University of Missouri will offer a health literacy study emphasis beginning this fall.

19 Feb 2010

Study shows prevalence of depression among low-income urban mothers

More than half of low-income urban mothers met the criteria for a diagnosis of depression at some point between two weeks and 14 months after giving birth, according to a study led by University of Rochester Medical Center researchers and published online by the journal Pediatrics.

19 Feb 2010

Ventas reports 7.8% increase in normalized FFO for year ended December 31, 2009

Ventas, Inc. said today that normalized Funds From Operations (“FFO”) for the year ended December 31, 2009 increased 7.8 percent to $409.0 million, from $379.5 million for the comparable 2008 period.

18 Feb 2010

Gentiva Health Services announces fourth-quarter and fiscal year 2009 results

Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported fourth quarter and full year fiscal 2009 results.

18 Feb 2010

Five Star Quality Care reports total revenues of $304.8M for fourth-quarter 2009

Five Star Quality Care, Inc. today announced its financial results for the quarter and year ended December 31, 2009.

18 Feb 2010

BPA has no effects on brain development: New study

This new study, which exposed pregnant rodents to a range of BPA dietary doses from low to high, concluded that BPA had no effects on brain development or behavior in their offspring that had been exposed to BPA in utero and throughout development. The robust study was conducted by highly qualified researchers at WIL Research Laboratories.

18 Feb 2010

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer's disease, a combination therapy that delays nursing home admission at 19 months would earn 43 percent patient share, according to surveyed U.S. neurologists. In comparison, in Europe, such an agent would earn a slightly lower patient share of 30 percent, according to surveyed European neurologists. This lower share estimate is possibly a result of higher price sensitivity of European markets.

18 Feb 2010

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.

18 Feb 2010

Nursing News and Research

Latest Nursing News and Research

Elsevier to celebrate medical education innovation at 60th AMSA convention

NHI reports normalized FFO of $16.65M for fourth-quarter 2009

PharMEDium Services participates in APSF Summit held in Phoenix, AZ

HTA executes purchase and sale agreement to acquire five building medical office portfolio in Indiana

WSNA holds informational picket to highlight issues critical to public health and safety

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

Recession swells Medicaid rolls, shrivels treasuries

Petzel takes oath to lead nation's largest integrated health care system

Accessing out of hours care: Challenging for UK palliative care patients

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Sacred Heart Medical Center fined $8,000 for failing to adhere to state and national H1N1 influenza safety standards

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

University of Missouri to offer health literacy courses for health professionals

Study shows prevalence of depression among low-income urban mothers

Ventas reports 7.8% increase in normalized FFO for year ended December 31, 2009

Gentiva Health Services announces fourth-quarter and fiscal year 2009 results

Five Star Quality Care reports total revenues of $304.8M for fourth-quarter 2009

BPA has no effects on brain development: New study

Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Nursing News and Research

Latest Nursing News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in